Clinical trial
Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey
NCT04386928 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey
- Lead sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2019
- Completion date
- March 16, 2021
- Enrollment
- 1,996 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic diseases, stem cell transplant complications